Ascendis Pharma

Home » Ascendis Pharma

Secondary

Ascendis Pharma

Ascendis Pharma is a biopharmaceutical company applying its TransCon technology to develop a pipeline of sustained release prodrug therapies with best-in-class profiles to address significant unmet medical needs in rare diseases.

Symbol

ASND

Last Closing Price
$59.00

Shares
2,600,000

Effective Date
February 22, 2018

Underwriters
J.P. Morgan, BofA Merrill Lynch, Credit Suisse Securities

To view the prospectus for Ascendis Pharma, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253